Wilhelm Stahl

Chief Technology Officer & Senior Vice President at Tricida, Inc.

Wilhelm Stahl

Wilhelm Stahl

Chief Technology Officer & Senior Vice President at Tricida, Inc.

Overview
Career Highlights

Rondaxe Deutschland
Rondaxe Enterprises LLC

RelSci Relationships

519

Birthday

1960

Age

59

Contact Data
Trying to get in touch with Wilhelm Stahl? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Wilhelm Stahl likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & President at Tricida, Inc.

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Symbiomix Therapeutics LLC

Relationship likelihood: Strong

Chief Development Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Former Chief Scientific Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Co-Founder & President at Sibling Capital LLC

Relationship likelihood: Strong

Chief Financial Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Former Partner at Bryan Cave LLP

Relationship likelihood: Strong

Chief Commercial Officer & Senior Vice President at Tricida, Inc.

Relationship likelihood: Strong

Paths to Wilhelm Stahl
Potential Connections via
Relationship Science
You
Wilhelm Stahl
Chief Technology Officer & Senior Vice President at Tricida, Inc.
Education
Ph.D Chemistry

The University of Bonn is a public research university located in Bonn, Germany. It was founded in its present form as the Rhein University on 18 October 1818 by Frederick William III, as the linear successor of the Kurkölnische Akademie Bonn (English: Academy of the Prince-elector of Cologne) which was founded in 1777. The University of Bonn offers a large number of undergraduate and graduate programs in a range of subjects and has 544 professors and 32,500 students. Its library holds more than five million volumes. Among its notable alumni and faculty are seven Nobel Laureates, three Fields Medalist, twelve Gottfried Wilhelm Leibniz Prize winners, Prince Albert, Pope Benedict XVI, Frederick III, Karl Marx, Heinrich Heine, Friedrich Nietzsche, Konrad Adenauer, and Joseph Schumpeter. The Times Higher Education World University Rankings 2016 and the Academic Ranking of World Universities 2015 ranked the University of Bonn as one of the 100 best universities in the world.

BS Chemistry

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Career History
Chief Technology Officer & Senior Vice President
2011 - 2017

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Head-Pharma Custom Manufacturing Business
2005 - 2008

Saltigo GmbH engages in the custom synthesis of chemical active ingredients and intermediates. It manufactures intermediates and active ingredients for the crop protection market; pharmaceutical intermediates and active pharmaceutical ingredients for pharmaceutical companies; and fine chemicals for non-life-science applications that include oils and waxes for industrial and cosmetic purposes, scents and aromas for cosmetics and foods, plastic additives for PVC and synthetic rubbers, special adhesives for the footwear industry, and chemicals for manufacturing OLEDs and similar compounds found in flat screens and solar modules. The company was founded in April 2006 and is headquartered in Leverkusen, Germany.

Medicinal Chemist
Prior

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Transactions
Details Hidden

Tricida, Inc. raised money in a private placement transaction

Details Hidden

Relypsa, Inc. raised money in a private placement transaction

Investments
Details Hidden

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wilhelm Stahl. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wilhelm Stahl's profile does not indicate a business or promotional relationship of any kind between RelSci and Wilhelm Stahl.